Literature DB >> 8307044

Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland.

M R Ekman1, M Leinonen, H Syrjälä, E Linnanmäki, P Kujala, P Saikku.   

Abstract

A complement fixation (CF) test, a micro-immunofluorescence (micro-IF) test and an enzyme immunoassay (EIA) using Re-lipopolysaccharide as antigen were compared in the diagnosis of chlamydial infection in 136 mainly elderly patients hospitalized with community-acquired pneumonia during a Chlamydia pneumoniae epidemic in Finland in 1986-1987. Chlamydial pneumonia was diagnosed in 58 (42.6%) of the 136 pneumonia patients; 44 (75.9%) of them could be shown by micro-IF to be caused by Chlamydia pneumoniae, three by Chlamydia psittaci and four by Chlamydia spp. Only 5 (11.4%) of 44 patients with Chlamydia pneumoniae pneumonia were IgM-positive, indicating that the majority of cases were reinfections. In this population of mainly elderly patients the CF test was insensitive, being positive in only 6 (10.3%) of 58 cases of chlamydial pneumonia. The EIA detected 72.4% of cases and micro-IF 87.9% of cases (including infections with Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia spp.). In the EIA 77% of positive cases were positive in serum samples taken a week apart, whereas the corresponding figure for micro-IF was 50%. In micro-IF the measurement of IgA antibody levels is recommended and IgM-positive sera should be retested after removal of IgG antibody to avoid false-positive findings due to presence of rheumatoid factor. The collection of a third serum sample, for instance one month after onset, is also recommended, since half of the patients showed a diagnostic response in the micro-IF only in the sera taken one month apart.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307044     DOI: 10.1007/BF02098463

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.

Authors:  M Kleemola; P Saikku; R Visakorpi; S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.

Authors:  R P Verkooyen; M A Hazenberg; G H Van Haaren; J M Van Den Bosch; R J Snijder; H P Van Helden; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria.

Authors:  M Nurminen; M Leinonen; P Saikku; P H Mäkelä
Journal:  Science       Date:  1983-06-17       Impact factor: 47.728

4.  A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

Review 5.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

6.  An epidemic of infections due to Chlamydia pneumoniae in military conscripts.

Authors:  M R Ekman; J T Grayston; R Visakorpi; M Kleemola; C C Kuo; P Saikku
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

7.  Pneumonia associated with the TWAR strain of Chlamydia.

Authors:  T J Marrie; J T Grayston; S P Wang; C C Kuo
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

8.  Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections.

Authors:  G Ozanne; J Lefebvre
Journal:  Can J Microbiol       Date:  1992-11       Impact factor: 2.419

9.  The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods.

Authors:  Y Kerttula; M Leinonen; M Koskela; P H Mäkelä
Journal:  J Infect       Date:  1987-01       Impact factor: 6.072

10.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  19 in total

1.  Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae.

Authors:  T O Messmer; J Martinez; F Hassouna; E R Zell; W Harris; S Dowell; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.

Authors:  Y K Wong; J M Sueur; C H Fall; J Orfila; M E Ward
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

3.  Laboratory diagnosis of Chlamydia pneumoniae infections.

Authors:  R W Peeling
Journal:  Can J Infect Dis       Date:  1995-07

4.  Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

Authors:  K Loens; T Beck; H Goossens; D Ursi; M Overdijk; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci.

Authors:  H M Freidank; H Vögele; K Eckert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

Review 6.  Chlamydiae as pathogens: new species and new issues.

Authors:  R W Peeling; R C Brunham
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

7.  Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies.

Authors:  P J Pussinen; T Vilkuna-Rautiainen; G Alfthan; K Mattila; S Asikainen
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

8.  Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.

Authors:  Corinna Hermann; Kathrin Graf; Annemarie Groh; Eberhard Straube; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia.

Authors:  M T Kauppinen; P Saikku; P Kujala; E Herva; H Syrjälä
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

10.  Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice.

Authors:  Dongming Lin; Mary Alice Smith; Catherine Champagne; John Elter; James Beck; Steven Offenbacher
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.